Pacer Advisors Portfolio holdings
AUM
$39.6B
1-Year Return
5.04%
This Quarter Return
+6.36%
1 Year Return
+5.04%
3 Year Return
+42.86%
5 Year Return
+91.64%
10 Year Return
+332.32%
AUM
$5.75B
AUM Growth
+$430M
(+8.1%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-18.82%
Top 10 Holdings %
Top 10 Hldgs %
27.15%
Holding
1,587
New
76
Increased
379
Reduced
937
Closed
183
Top Buys
| 1 |
HP
HPQ
|
+$6.72M |
| 2 |
Newmont
NEM
|
+$6.32M |
| 3 |
General Mills
GIS
|
+$6.24M |
| 4 |
TJX Companies
TJX
|
+$5.82M |
| 5 |
Ford
F
|
+$5.76M |
Top Sells
| 1 |
Iron Mountain
IRM
|
+$16.2M |
| 2 |
Apple
AAPL
|
+$15.9M |
| 3 |
Amazon
AMZN
|
+$14.5M |
| 4 |
Microsoft
MSFT
|
+$13.1M |
| 5 |
GDS Holdings
GDS
|
+$7.93M |
Sector Composition
| 1 | Real Estate | 17.47% |
| 2 | Technology | 14.61% |
| 3 | Consumer Discretionary | 9.29% |
| 4 | Healthcare | 7.36% |
| 5 | Communication Services | 6.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Kymera Therapeutics
KYMR
$3.3B
| $47K | ﹤0.01% |
+1,208
| New | +$47K |
|
1302
Nkarta
NKTX
$143M
| $47K | ﹤0.01% |
1,429
+914
| +177% | +$30.1K |
|
1303
AnaptysBio
ANAB
$637M
| $46K | ﹤0.01% |
2,122
+510
| +32% | +$11.1K |
|
1304
Coupang
CPNG
$59.2B
| $46K | ﹤0.01% |
+934
| New | +$46K |
|
1305
Krystal Biotech
KRYS
$3.98B
| $46K | ﹤0.01% |
602
-6
| -1% | -$458 |
|
1306
Protagonist Therapeutics
PTGX
$3.71B
| $46K | ﹤0.01% |
1,780
-178
| -9% | -$4.6K |
|
1307
Aldeyra Therapeutics
ALDX
$333M
| $45K | ﹤0.01% |
+3,810
| New | +$45K |
|
1308
Quince Therapeutics
QNCX
$86.5M
| $45K | ﹤0.01% |
1,244
+114
| +10% | +$4.12K |
|
1309
Companhia Siderúrgica Nacional
SID
$1.99B
| $45K | ﹤0.01% |
6,678
+2,716
| +69% | +$18.3K |
|
1310
Alaunos Therapeutics
TCRT
$4.83M
| $45K | ﹤0.01% |
84
+9
| +12% | +$4.82K |
|
|
SPPI
1311
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $45K | ﹤0.01% |
13,670
+540
| +4% | +$1.78K |
|
1312
Imperial Oil
IMO
$46.6B
| $44K | ﹤0.01% |
1,803
-95
| -5% | -$2.32K |
|
|
DMTK
1313
DELISTED
DermTech, Inc. Common Stock
DMTK
| $44K | ﹤0.01% |
+860
| New | +$44K |
|
|
RDUS
1314
DELISTED
Radius Health, Inc.
RDUS
| $43K | ﹤0.01% |
2,050
-962
| -32% | -$20.2K |
|
1315
Anavex Life Sciences
AVXL
$823M
| $42K | ﹤0.01% |
+2,786
| New | +$42K |
|
1316
CEMIG Preferred Shares
CIG
$5.81B
| $42K | ﹤0.01% |
34,654
+13,190
| +61% | +$16K |
|
1317
Vaxcyte
PCVX
$4.15B
| $42K | ﹤0.01% |
2,122
+850
| +67% | +$16.8K |
|
|
AGEN
1318
Agenus
AGEN
$154M
| $41K | ﹤0.01% |
777
-12
| -2% | -$633 |
|
1319
C4 Therapeutics
CCCC
$194M
| $41K | ﹤0.01% |
+1,096
| New | +$41K |
|
1320
CyberArk
CYBR
$23.8B
| $41K | ﹤0.01% |
314
-15
| -5% | -$1.96K |
|
|
KLRS
1321
Kalaris Therapeutics, Inc. Common Stock
KLRS
$80M
| $41K | ﹤0.01% |
76
+35
| +85% | +$18.9K |
|
|
ALBO
1322
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $41K | ﹤0.01% |
1,151
+82
| +8% | +$2.92K |
|
1323
Enanta Pharmaceuticals
ENTA
$178M
| $39K | ﹤0.01% |
798
-366
| -31% | -$17.9K |
|
1324
Oric Pharmaceuticals
ORIC
$1.05B
| $39K | ﹤0.01% |
+1,572
| New | +$39K |
|
1325
Gossamer Bio
GOSS
$787M
| $38K | ﹤0.01% |
4,059
+506
| +14% | +$4.74K |
|